Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Radiation Retinopathy With Intravitreal Aflibercept Injection 2.0mg

NCT01579760 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT01579760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01579760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Radiation Retinopathy With Intravitreal Aflibercept Injection 2.0mg
Lead sponsor
Washington University School of Medicine
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2012
Completion date
March 27, 2019
Enrollment
9 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

macular edema, radiation retinopathy